Tridek’s €16 Million Fundraising

UGGC Avocats advised Tridek on the deal. Tridek-One, a biotech start-up specialized in the research and development of CD31 agonists to restore immune balance, in its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here